Defining a new threshold for PSA outcomes in untreated prostate cancer.

被引：0
|
作者：
Beekman, KW [1 ]
Wilton, A [1 ]
Heller, G [1 ]
Bianco, FJ [1 ]
Lilja, H [1 ]
Slovin, S [1 ]
Scardino, PT [1 ]
Scher, HI [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4587
引用
收藏
页码：403S / 403S
页数：1
相关论文
共 50 条
  • [21] Should a family history of prostate cancer affect the total PSA or PSA velocity threshold for biopsy?
    Kundu, Shilajit
    HArshad, Faizan
    Loeb, Stacy
    Roehl, Kimberly A.
    Mondo, Dana M.
    Gashti, Sara N.
    Griffin, Christopher R.
    Catalona, William J.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 714 - 715
  • [22] Early detection of prostate cancer. Is serum PSA testing alone sufficient?
    Boergermann, C.
    vom Dorp, F.
    Breuer, G.
    Kliner, S.
    Ruebben, H.
    UROLOGE, 2010, 49 (11): : 1351 - +
  • [23] Complexed PSA and total gland volume are significant predictors of prostate cancer.
    Levine, R
    Cheli, CD
    Kolker, J
    Roberts, SB
    CLINICAL CHEMISTRY, 2001, 47 (06) : A129 - A129
  • [24] Complexed PSA combined with clinical parameters enhances prediction of prostate cancer.
    Cheli, CD
    Thiel, RP
    Horninger, W
    Bartsch, G
    CLINICAL CHEMISTRY, 2003, 49 (06) : A98 - A98
  • [25] Serum PSA recurrence in patients with pT2 prostate cancer.
    McLeod, DG
    Sesterhenn, IS
    Moul, JW
    Mostofi, FK
    JOURNAL OF UROLOGY, 1998, 159 (05): : 61 - 61
  • [26] Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer
    Schroeder, Fritz H.
    Roobol, Monique J.
    CURRENT OPINION IN UROLOGY, 2009, 19 (03) : 227 - 231
  • [27] New studies on PSA screening for prostate cancer
    Martin
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (11) : 605 - 605
  • [28] New recommendations for prostate cancer screening with PSA
    Julia-Romero, C.
    Rechi-Sierra, K.
    Juan-Escudero, J. U.
    MEDICINA DE FAMILIA-SEMERGEN, 2021, 47 (05): : 342 - 347
  • [29] Natural course of primary, untreated, localized prostate cancer. The Orebro study
    Johansson, JE
    UROLOGE-AUSGABE A, 1996, 35 (06): : 446 - 448
  • [30] Analysis of monotherapy prostate brachytherapy in patients with prostate cancer. Initial PSA and Gleason are important for recurrence?
    Galego, Pedro
    Silva, Fernando C.
    Pinheiro, Luis Campos
    INTERNATIONAL BRAZ J UROL, 2015, 41 (02): : 353 - 359
12345